
Why Medical Companies Win Rescheduling, Whatever Happens to Adult-Use
This week, what is perhaps the most consequential hearing in the history of the US, and indeed the global cannabis

This week, what is perhaps the most consequential hearing in the history of the US, and indeed the global cannabis

US cannabis rescheduling is unlikely to trigger a land grab. Instead, it has the potential to reprice medical intellectual property

We are proud to be supported by some of the cannabis industry’s most forward-thinking and influential businesses. Their backing helps create an environment where innovation thrives, meaningful connections are made, and bold ideas can take shape.

In the run-up to Cannabis Europa 2023, Prohibition Partners’ CEO Stephen Murphy caught up with Aras Azadian, co-founder and CEO of Avicanna. Stephen and Aras discuss Avicanna’s landmark partnership with Canadian pharmacy giant Shoppers Drug Mart, alongside reviewing differences between the Canadian and European industries, patient access and affordability and what to look forward to in the emerging European market.

AVICANNA Canada’s Shoppers Drug Mart is handing over the reins of its cannabis vertical to this biopharma company Shoppers Drug